Extract from the Register of European Patents

EP About this file: EP1613296

EP1613296 - METHODS FOR TREATMENT OF PARKINSON'S DISEASE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  07.05.2010
Database last updated on 07.04.2026
Most recent event   Tooltip07.05.2010No opposition filed within time limitpublished on 09.06.2010  [2010/23]
Applicant(s)For all designated states
Newron Pharmaceuticals S.p.A.
Via L. Ariosto, 21
20091 Bresso (MI) / IT
[2006/02]
Inventor(s)01 / RUGGERO, Fariello
Via della Vittoria, 22
I-21016 Luino / IT
02 / CATTANEO, Carlo
Via C. Armellini, 31
I-20161 Milano / IT
03 / SALVATI, Patricia
Via Valera, 16/c
I-20020 Arese / IT
04 / BENATTI, Luca
Via della Repubblica, 43
I-20093 S. Maurizio al Lambro / IT
 [2006/02]
Representative(s)Minoja, Fabrizio
Bianchetti & Minoja S.r.l.
Via Plinio, 63
20129 Milano / IT
[N/P]
Former [2006/02]Minoja, Fabrizio
Bianchetti Bracco Minoja S.r.l. Via Plinio, 63
20129 Milano / IT
Application number, filing date04726590.508.04.2004
[2006/02]
WO2004IB01408
Priority number, dateUS20030462205P11.04.2003         Original published format: US 462205 P
[2006/02]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004089353
Date:21.10.2004
Language:EN
[2004/43]
Type: A2 Application without search report 
No.:EP1613296
Date:11.01.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 21.10.2004 takes the place of the publication of the European patent application.
[2006/02]
Type: B1 Patent specification 
No.:EP1613296
Date:01.07.2009
Language:EN
[2009/27]
Search report(s)International search report - published on:EP16.12.2004
ClassificationIPC:A61K31/16, A61P25/16
[2006/02]
CPC:
A61K31/165 (EP,US); A61K31/16 (EP,KR,US); A61K31/137 (EP,US);
A61K31/473 (EP,US); A61K31/4745 (EP,US); A61K31/475 (EP,US);
A61K31/48 (EP,US); A61K31/485 (EP,US); A61K31/498 (EP,US);
A61K31/4985 (EP,US); A61K31/55 (EP,US); A61K45/06 (EP,US);
A61P25/00 (EP); A61P25/16 (EP) (-)
C-Set:
A61K31/137, A61K2300/00 (US,EP);
A61K31/16, A61K2300/00 (EP,US);
A61K31/473, A61K2300/00 (US,EP);
A61K31/48, A61K2300/00 (US,EP);
A61K31/498, A61K2300/00 (EP,US)
(-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/02]
Extension statesALNot yet paid
HRNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:VERFAHREN ZUR BEHANDLUNG VON PARKINSON-KRANKHEIT[2006/02]
English:METHODS FOR TREATMENT OF PARKINSON'S DISEASE[2006/02]
French:PROCEDES DE TRAITEMENT DE LA MALADIE DE PARKINSON[2006/02]
Entry into regional phase04.10.2005National basic fee paid 
04.10.2005Designation fee(s) paid 
04.10.2005Examination fee paid 
Examination procedure04.10.2005Amendment by applicant (claims and/or description)
04.10.2005Examination requested  [2006/02]
16.12.2005Despatch of a communication from the examining division (Time limit: M08)
09.08.2006Reply to a communication from the examining division
05.12.2006Despatch of a communication from the examining division (Time limit: M04)
06.04.2007Reply to a communication from the examining division
19.11.2007Date of oral proceedings
25.01.2008Communication of intention to grant the patent
25.01.2008Minutes of oral proceedings despatched
14.05.2008Fee for grant paid
14.05.2008Fee for publishing/printing paid
Divisional application(s)EP09154864.4  / EP2070526
Opposition(s)06.04.2010No opposition filed within time limit [2010/23]
Fees paidRenewal fee
24.04.2006Renewal fee patent year 03
25.04.2007Renewal fee patent year 04
24.04.2008Renewal fee patent year 05
24.04.2009Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]   ANONYMOUS: "Newron Releases Positive Preliminary Phase II Data for Salfinamide in Parkinson's Disease", PRESS RELEASE OF 03.01.03, XP002290820, Retrieved from the Internet [retrieved on 20040801] [X] 1-56 * the whole document *
Examination  STOCCHI ET AL: "SYMPTOM RELIEF IN PARKINSON DISEASE BY SAFINAMIDE", NEUROLOGY, vol. 67, no. SUPPL1, 2006 - 2006, pages S24 - S29, XP009073546 * figure 3 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.